Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis

Figure 4

Expression and survival analysis of MAD2L1: (a) the mRNA levels of MAD2L1 in TCGA in HCC tissues and adjacent liver tissues; (b) the mRNA levels of MAD2L1 in paired HCC and adjacent liver tissues in TCGA database; (c) Kaplan-Meier survival analysis for the overall survival of MAD2L1 in HCC; (d) Kaplan-Meier survival analysis for the recurrence-free survival of MAD2L1 in HCC.

(a)

(b)

(c)

(d)